NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANEB

Based on 1 analyst offering 12 month price targets for Anebulo Pharmaceuticals Inc

Min Forecast
$3.00+69.49%
Avg Forecast
$3.00+69.49%
Max Forecast
$3.00+69.49%

Should I buy or sell ANEB stock?

Based on 1 analyst offering ratings for Anebulo Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANEB stock forecasts and price targets.

ANEB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-15

1 of 1

ANEB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANEB$1.77$3.00+69.49%Strong Buy
ADAP$0.27$1.35+393.43%Hold
BMEA$1.93$11.00+469.95%Strong Buy
SRZN$8.57$32.00+273.40%Buy
AKTX$1.15N/AN/A

Anebulo Pharmaceuticals Stock Forecast FAQ

Is Anebulo Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ANEB) stock is to Strong Buy ANEB stock.

Out of 1 analyst, 1 (100%) are recommending ANEB as a Strong Buy, 0 (0%) are recommending ANEB as a Buy, 0 (0%) are recommending ANEB as a Hold, 0 (0%) are recommending ANEB as a Sell, and 0 (0%) are recommending ANEB as a Strong Sell.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.

What is ANEB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ANEB price target, the average ANEB price target is $3.00, with the highest ANEB stock price forecast at $3.00 and the lowest ANEB stock price forecast at $3.00.

The Wall Street analyst predicted that Anebulo Pharmaceuticals's share price could reach $3.00 by May 15, 2026. The average Anebulo Pharmaceuticals stock price prediction forecasts a potential upside of 69.49% from the current ANEB share price of $1.77.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.